CATALANO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 350
NA - Nord America 343
AS - Asia 189
SA - Sud America 4
Totale 886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 342
IE - Irlanda 112
HK - Hong Kong 106
IT - Italia 94
SE - Svezia 45
JO - Giordania 40
CN - Cina 25
RU - Federazione Russa 23
DE - Germania 18
FR - Francia 18
CH - Svizzera 15
AT - Austria 13
IN - India 10
SG - Singapore 8
BR - Brasile 4
FI - Finlandia 3
GB - Regno Unito 3
ES - Italia 2
BE - Belgio 1
CA - Canada 1
HR - Croazia 1
NL - Olanda 1
UA - Ucraina 1
Totale 886
Salva come PNG Salva come JPEG
Città #
Dublin 110
Hong Kong 75
Ashburn 56
Chandler 51
Moscow 23
Bremen 17
Shanghai 16
Bern 15
Altamura 14
Lawrence 14
Fairfield 13
Vienna 13
Florence 11
Seattle 9
Wilmington 9
New York 8
Princeton 8
Beijing 7
Boston 7
Decatur 7
Pune 7
Singapore 7
Woodbridge 7
Paris 6
Rome 6
West Jordan 6
Ann Arbor 5
Cambridge 5
Houston 5
Washington 5
Fontebuona 4
Grottammare 4
Helsinki 3
Ladispoli 3
Livorno 3
Medford 3
San Diego 3
Boardman 2
Casier 2
Enna 2
Falls Church 2
Fucecchio 2
Grosseto 2
Hillsboro 2
Jaraguá do Sul 2
Madrid 2
Milan 2
Padova 2
Pescara 2
São Paulo 2
Almè 1
Bientina 1
Brossard 1
Brussels 1
Buffalo 1
Capannoli 1
Cascina 1
Chennai 1
Clifton 1
Council Bluffs 1
Dongguan 1
Kilburn 1
Leawood 1
London 1
Manhasset 1
Poggibonsi 1
Recanati 1
Stockholm 1
Varanasi 1
Vellore 1
Vico Equense 1
Xiamen 1
Totale 613
Salva come PNG Salva come JPEG
Nome #
Germline mutations in MSH2 and ATM gene in patients with GIST (gastrointestinal stromal tumor) and second epitelial tumors 58
Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand? 56
Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study 52
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 49
A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coin 43
Inflammation in Urological Malignancies: The Silent Killer 38
Gastric and colonic metastasis from NSCLC A very unusual case report 36
Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma 34
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? 31
Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature review 29
The gut microbiome and efficacy of cancer immunotherapy 29
Current status and future perspectives in HER2 positive advanced gastric cancer 28
Liquid biopsy in colorectal cancer: No longer young, but not yet old 28
Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments 25
Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy 25
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice 24
Systemic Sclerosis Association with Malignancy 23
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials 21
Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy 21
DNA repair deficiency as circulating biomarker in prostate cancer 20
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors 20
Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment 20
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma 19
Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge 17
Capecitabine as a Second-line Treatment for Older Patients with Pancreatic Cancer 16
Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope? 15
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next 15
Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas 14
Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors 14
The latest developments in biomarkers predicting response to immunotherapy 13
FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer 11
Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers 11
Second line of treatment for HER2-positive gastric cancer: an evolving issue 10
Editorial: Microbiota and metabolites in cancer immunotherapy 10
Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysis 8
Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer 8
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities? 8
Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis-what is currently known? 6
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib 6
Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually? 5
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 4
Personalized medicine for metastatic prostate cancer: The paradigm of PARP inhibitors 4
The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer 4
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 3
Immunotherapy-related biomarkers: Confirmations and uncertainties 3
Immune combinations and complete response: a new hope for metastatic renal cell carcinoma 3
Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients 2
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab 2
Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer 2
Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma 2
Tyrosine kinase and immune checkpoints inhibitors in favorable risk metastatic renal cell carcinoma: Trick or treat? 1
Tumor microenvironment in renal cell carcinoma: what is the current impact? 1
Cancer management during the COVID-19 world pandemic 1
Totale 948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 5 0 0 12 2 8 3 2 2
2021/202262 2 0 0 0 0 8 0 22 3 2 3 22
2022/2023429 10 44 6 37 15 68 97 37 53 18 16 28
2023/2024423 13 34 50 21 31 65 26 116 18 49 0 0
Totale 948